Technical Analysis for SDGR - Schrodinger, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 21.52 | -1.19% | -0.26 |
SDGR closed down 1.19 percent on Friday, May 31, 2024, on 81 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Jun 18
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Oversold Stochastic | Weakness | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | -1.19% | |
| Stochastic Buy Signal | Bullish | -1.19% | |
| NR7 | Range Contraction | -1.19% | |
| NR7-2 | Range Contraction | -1.19% | |
| Narrow Range Bar | Range Contraction | -1.19% | |
| Oversold Stochastic | Weakness | -1.19% | |
| New 52 Week Closing Low | Bearish | 0.51% | |
| Spinning Top | Other | 0.51% | |
| NR7 | Range Contraction | 0.51% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 1 day ago |
| Up 2% | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| 10 DMA Resistance | 1 day ago |
| Up 1% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/18/2024
Schrödinger, Inc. provides chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. Schrödinger was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in August 1990 and is headquartered in New York, NY.
Sector: Healthcare
Industry: Health Information Services
Keywords: Drug Discovery Materials Science Simulation Software Pre Clinical Development
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Drug Discovery Materials Science Simulation Software Pre Clinical Development
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 59.24 |
| 52 Week Low | 20.8 |
| Average Volume | 726,120 |
| 200-Day Moving Average | 28.30 |
| 50-Day Moving Average | 24.43 |
| 20-Day Moving Average | 22.70 |
| 10-Day Moving Average | 22.07 |
| Average True Range | 0.97 |
| RSI (14) | 37.11 |
| ADX | 4.8 |
| +DI | 23.45 |
| -DI | 22.17 |
| Chandelier Exit (Long, 3 ATRs) | 23.84 |
| Chandelier Exit (Short, 3 ATRs) | 24.13 |
| Upper Bollinger Bands | 24.20 |
| Lower Bollinger Band | 21.19 |
| Percent B (%b) | 0.11 |
| BandWidth | 13.24 |
| MACD Line | -0.80 |
| MACD Signal Line | -0.77 |
| MACD Histogram | -0.0274 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 22.72 | ||||
| Resistance 3 (R3) | 22.84 | 22.56 | 22.52 | ||
| Resistance 2 (R2) | 22.56 | 22.25 | 22.50 | 22.45 | |
| Resistance 1 (R1) | 22.04 | 22.07 | 21.90 | 21.92 | 22.39 |
| Pivot Point | 21.76 | 21.76 | 21.69 | 21.70 | 21.76 |
| Support 1 (S1) | 21.24 | 21.45 | 21.10 | 21.12 | 20.65 |
| Support 2 (S2) | 20.96 | 21.27 | 20.90 | 20.59 | |
| Support 3 (S3) | 20.44 | 20.96 | 20.52 | ||
| Support 4 (S4) | 20.32 |
